NWBO has been well positioned to maintain independent control of their situation. Even the board of directors can be controlled by just 33.3333333% of the shares. The only leverage I believe I have is with my understanding of Direct and it's component activation targets. The way it works makes clear to me that my due diligence has led me to correct conclusions. Of course using this potential leverage is kind of like shooting oneself in the foot when considering the potential outcome on long term investment should others start to catch up too quickly. This really only helps to influence shorter term thinking if there is strong desire to maintain a long term outlook and it's associated value. That is what I hope management is banking on and if so then further clues about how Direct works and why would not be helpful to the long term value they believe their product lines might help them achieve for themselves and us and create the incentive to be more forthright with long term supporters. I don't like putting myself in this position but the time has come for an attitude adjustment about timelines for the sake of patients who want this treatment and shareholders who have been very patient. Best wishes.
News 
Market Data 
Discover 
